Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Answers
Mobile
Yahoo
Search
No matching results for ''
Tip: Try a valid symbol or a specific company name for relevant results
Mail
Finance Home
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
The New Investors
All Markets Summit
Give Feedback
Australia markets closed
ALL ORDS
6,940.60
-165.10
(
-2.32%
)
ASX 200
6,673.30
-160.70
(
-2.35%
)
AUD/USD
0.7746
-0.0134
(
-1.70%
)
✉️ Free sign-up
Get the news straight to your inbox every day.
Stay in the loop every day with Yahoo Finance's free Fully Briefed newsletter.
Vir Biotechnology, Inc. (VIR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
61.99
-2.12 (-3.31%)
As of 11:03AM EST. Market open.
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
Total revenue
75,614
8,091
10,668
2,708
Operating expenses
Research development
268,247
148,472
100,229
62,512
Selling general and administrative
59,702
37,598
29,131
21,693
Total operating expenses
327,949
186,070
129,360
84,205
Operating income or loss
-252,335
-177,979
-118,692
-81,497
Total other income/expenses net
-8,714
-5,061
-212
83
Income before tax
-256,554
-174,529
-116,364
-80,776
Income tax expense
233
154
-480
-10,924
Income from continuing operations
-256,787
-174,683
-115,884
-69,852
Net income
-256,787
-174,683
-115,884
-69,852
Net income available to common shareholders
-256,787
-174,683
-115,789
-69,852
Basic EPS
-
-5.76
-1.52
-0.72
Diluted EPS
-
-5.76
-1.52
-0.72
Basic average shares
-
30,350
76,050
96,913
Diluted average shares
-
30,350
76,050
96,913
EBITDA
-
-173,462
-115,936
-81,065
© 2021 Verizon Media. All rights reserved.
Data disclaimer
Help
Suggestions
Privacy Dashboard
Privacy (updated)
About our ads
Terms (updated)